Kathleen McGroddy-Goetz - 08 Jun 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ Rachel Malina, Attorney-in-Fact for Kathleen McGroddy-Goetz
Issuer symbol
TNDM
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 16:57:12 UTC
Previous filing
27 May 2022
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1,220 +43% $0.000000 4,055 08 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +1,220 $0.000000 1,220 08 Jun 2022 Common Stock 1,220 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F3 RSUs granted on 6/8/2020 vest over a period of three years in equal annual installments on the anniversary of the grant.